BackAkero Therapeutics Overview

Akero Therapeutics Net Income

Profitability analysis for AKRO.

Quarterly Net Income

-$81.57M
12.19% YoY

As of Sep 2025

Annual Net Income (TTM)

-$292.82M
23.44% YoY

Trailing 12 months ending Sep 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...